[HTML][HTML] Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions
B Serrano, S de Sanjosé, S Tous, B Quiros… - European journal of …, 2015 - Elsevier
Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and
help to reduce other HPV-related cancers. We aimed to estimate the relative contribution …
help to reduce other HPV-related cancers. We aimed to estimate the relative contribution …
Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a …
E Bernard, M Pons-Salort, M Favre, I Heard… - BMC infectious …, 2013 - Springer
Background Mucosal human papillomavirus (HPV) infection is a necessary cause of cervical
cancer. Vaccine and non-vaccine genotype prevalences may change after vaccine …
cancer. Vaccine and non-vaccine genotype prevalences may change after vaccine …
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
B Serrano, L Alemany, S Tous, L Bruni… - Infectious agents and …, 2012 - Springer
Background Information on human papillomavirus (HPV) type distribution is necessary to
evaluate the potential impact of current and future HPV vaccines. We estimated the relative …
evaluate the potential impact of current and future HPV vaccines. We estimated the relative …
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease
EA Joura, KA Ault, FX Bosch, D Brown, J Cuzick… - … Biomarkers & Prevention, 2014 - AACR
Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV)
types (6/11/16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the …
types (6/11/16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the …
[HTML][HTML] Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva
S De Sanjosé, L Alemany, J Ordi, S Tous… - European journal of …, 2013 - Elsevier
Background Human papillomavirus (HPV) contribution in vulvar intraepithelial lesions (VIN)
and invasive vulvar cancer (IVC) is not clearly established. This study provides novel data …
and invasive vulvar cancer (IVC) is not clearly established. This study provides novel data …
Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade …
M Paz-Zulueta, L Álvarez-Paredes, JC Rodríguez Díaz… - BMC cancer, 2018 - Springer
Background The new nine-valent vaccine against human papillomavirus (HPV) includes the
four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV …
four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV …
Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6/11/16/18/31/33/45/52 and 58
S De Sanjose, B Serrano, S Tous, M Alejo… - JNCI Cancer …, 2018 - academic.oup.com
Background Many countries, mainly high-and upper-middle income, have implemented
human papillomavirus (HPV) vaccination programs, with 47 million women receiving the full …
human papillomavirus (HPV) vaccination programs, with 47 million women receiving the full …
Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
D Riethmuller, AC Jacquard, J Lacau St Guily… - BMC Public Health, 2015 - Springer
Abstract Background Human Papillomavirus (HPV) infection is known to be associated with
a number of conditions including cervical, vaginal, vulvar, penile, anal neoplasias and …
a number of conditions including cervical, vaginal, vulvar, penile, anal neoplasias and …
[HTML][HTML] Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential …
S Hartwig, JJ Baldauf, G Dominiak-Felden… - Papillomavirus …, 2015 - Elsevier
Introduction A second generation HPV vaccine has been developed for the prevention of
anogenital cancers and precancerous lesions of the cervix, vulva, vagina, anus and of …
anogenital cancers and precancerous lesions of the cervix, vulva, vagina, anus and of …
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
S de Sanjose, WGV Quint, L Alemany… - The lancet …, 2010 - thelancet.com
Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in
invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We …
invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We …